Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (147)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Tucatinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Tucatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Tuvusertib	DNA Damage Response Inhibitor (WEE1/ATR/CHK1)	Solid Tumour
Molecule Tuvusertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Ulixertinib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Ulixertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Uprosertib	AKT Inhibitor	Solid Tumour
Molecule Uprosertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Vandetanib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Vandetanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Varlitinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Varlitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Vatalanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Vatalanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Veliparib	PARP Inhibitor	Solid Tumour
Molecule Veliparib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Vemurafenib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Vemurafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Vorasidenib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Vorasidenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Vorolanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Vorolanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Voruciclib	CDK Inhibitor	Solid Tumour
Molecule Voruciclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor

Tucatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Tuvusertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Ulixertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Uprosertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Vandetanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Varlitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Vatalanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Veliparib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Vemurafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Vorasidenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Vorolanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Voruciclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor

‹ 1 … 10 11 12 13 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (147)

Tucatinib

Tuvusertib

Ulixertinib

Uprosertib

Vandetanib

Varlitinib

Vatalanib

Veliparib

Vemurafenib

Vorasidenib

Vorolanib

Voruciclib

Tucatinib

Tuvusertib

Ulixertinib

Uprosertib

Vandetanib

Varlitinib

Vatalanib

Veliparib

Vemurafenib

Vorasidenib

Vorolanib

Voruciclib